These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1758532)

  • 1. Hyperlipidemia in stable renal transplant recipients.
    Divakar D; Bailey RR; Frampton CM; George PM; Walmsley TA; Murphy J
    Nephron; 1991; 59(3):423-8. PubMed ID: 1758532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing plasma lipid profiles including lipoprotein (a) concentrations in renal transplant recipients.
    Wheeler DC; Morgan R; Thomas DM; Seed M; Rees A; Moore RH
    Transpl Int; 1996; 9(3):221-6. PubMed ID: 8723190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy.
    Bittar AE; Ratcliffe PJ; Richardson AJ; Raine AE; Jones L; Yudkin PL; Carter R; Mann JI; Morris PJ
    Transplantation; 1990 Dec; 50(6):987-92. PubMed ID: 2256173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid disorders in renal transplant recipients.
    Ponticelli C; Barbi GL; Cantaluppi A; De Vecchi A; Annoni G; Donati C; Cecchettin M
    Nephron; 1978; 20(4):189-95. PubMed ID: 345139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia in long-term survivors of pediatric renal transplantation.
    Sharma AK; Myers TA; Hunninghake DB; Matas AJ; Kashtan CE
    Clin Transplant; 1994 Jun; 8(3 Pt 1):252-7. PubMed ID: 8061364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for the development and progression of dyslipidemia after heart transplantation.
    Akhlaghi F; Jackson CH; Parameshwar J; Sharples LD; Trull AK
    Transplantation; 2002 Apr; 73(8):1258-64. PubMed ID: 11981418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks for hyperlipidemia.
    Nestruck AC; Davignon J
    Cardiol Clin; 1986 Feb; 4(1):47-56. PubMed ID: 2871933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
    Seymen P; Yildiz M; Türkmen MF; Titiz MI; Seymen HO
    Transplant Proc; 2009 Dec; 41(10):4181-3. PubMed ID: 20005364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipid pattern unifies following renal transplantation in children.
    Müller T; Koeppe S; Arbeiter K; Luckner D; Salzer U; Balzar E; Aufricht C
    Pediatr Nephrol; 2003 Sep; 18(9):939-42. PubMed ID: 12883978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.
    Tory R; Sachs-Barrable K; Goshko CB; Hill JS; Wasan KM
    Transplantation; 2009 Jul; 88(1):62-8. PubMed ID: 19584682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on post-transplant dyslipidemia in kidney transplant patients.
    Marubayashi S; Ohdan H; Tashiro H; Tokita D; Onoe T; Hayamizu K; Asahara T; Doi S; Okumoto S; Tanji C; Kawai T; Taniguchi Y; Fukuda Y; Dohi K
    Hiroshima J Med Sci; 2005 Jun; 54(2):39-45. PubMed ID: 15991596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of multiple pharmaco-therapy in the pathogenesis of hyperlipidemia after renal transplantation.
    Chan MK; Varghese Z; Persaud JW; Fernando ON; Moorhead JF
    Clin Nephrol; 1981 Jun; 15(6):309-13. PubMed ID: 6113904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlipidaemia in renal transplant patients.
    Aakhus S; Dahl K; Widerøe TE
    J Intern Med; 1996 May; 239(5):407-15. PubMed ID: 8642233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities in the composition of serum high density lipoprotein in renal transplant recipients.
    Jung K; Neumann R; Scholz D; Nugel E
    Clin Nephrol; 1982 Apr; 17(4):191-4. PubMed ID: 7042146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term study on hyperlipidemia in stable renal transplant recipients.
    Tse KC; Lam MF; Yip PS; Li FK; Lai KN; Chan TM
    Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidemia in stable renal transplant recipients.
    Ong-Ajyooth L; Sirisalee K; Shayakul C; Vareesangthip K; Vasuvattakul S; Chirawong P; Vanichakarn S; Nimmannit S; Ong-Ajyooth S; Nilwarangkur S
    Transplant Proc; 1994 Aug; 26(4):2062-4. PubMed ID: 8066670
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlipidemia after renal transplantation: treatment with gemfibrozil.
    Chan TM; Cheng IK; Tam SC
    Nephron; 1994; 67(3):317-21. PubMed ID: 7936022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with low-dose pravastatin and fish oil in post-renal transplantation dislipidemia.
    Grekas D; Kassimatis E; Makedou A; Bacharaki D; Bamichas G; Tourkantonis A
    Nephron; 2001 Aug; 88(4):329-33. PubMed ID: 11474227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.